EU waives Takeda/Shire merger commitments
Credit: Jonathan Weiss/Shutterstock
The European Commission has waived the conditions it imposed on Takeda’s 2018 takeover of rival Shire due to “permanent, significant and unforeseeable developments” that occurred as the drugmaker attempted to complete its required divestiture.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now